Overview

Detailed Summary

Brooks Laboratories Limited is a pharmaceutical manufacturing company specializing in the production of injectables, tablets, and dry syrups. It operates on a contract basis with major pharmaceutical clients.
The company has two cGMP compliant manufacturing plants located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. The Vadodara facility is notably approved by the European Medicine Agency, underlining its international quality standards.
Due to strategic upgrades, Brooks Labs has enhanced its equipment and processes leading to substantial capacity improvements, especially the doubling of capacity for injectables at the Baddi plant.
Brooks Labs partners with major pharmaceutical companies such as Zydus Cadila and Wockhardt and supplies critically needed products in the parental care segment across India.
The company's Vadodara plant, recognized as the world's largest dedicated EU-certified facility, has enabled it to boost its presence and credentials in both domestic and international markets.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 205 Cr
Volatility: High Risk
P/E Ratio: 8.3
Industry P/E: 33.7
PEG Ratio: 0.1
P/B Ratio: 1.6
52W High: 165.95
52W Low: 36.90

Sales CAGR

1Y: 3.86%
3Y: 2.36%
5Y: 3.45%
10Y: 0.35%

Profit CAGR

1Y: 49.11%
3Y: 66.10%
5Y: —
10Y: -12.95%

ROE

TTM: 20.04%
3Y: -1.49%
5Y: -5.00%
10Y: -6.31%

ROCE

TTM: 19.30%
3Y: -0.31%
5Y: -1.20%
10Y: -2.64%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BDH		361.30	208 Cr	19.20	2.74	1.39	14.04	19.30	10.92
BROOKS		66.50	195 Cr	7.95	1.59	0.00	20.04	19.30	16.59
SPML		214.10	188 Cr	14.44	2.64	0.00	18.31	18.42	13.68
OXYGENTAPH		50.19	186 Cr	-10.57	0.00	0.00	41.16	-26.02	-14.69
ANL		255.10	185 Cr	36.79	6.02	0.00	14.29	16.99	12.01
SANJIVIN		149.60	181 Cr	27.02	3.75	0.00	13.87	16.29	7.62
CORALAB		502.50	177 Cr	10.83	0.85	0.00	7.83	10.89	6.81
Median: 7 Co.	—	214.10	186 Cr	14.44	2.64	0.00	14.29	16.99	10.92

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	22	18	18	21	38	23	26	23	17	20
Expenses	21	17	18	19	37	22	22	21	16	20
Operating Profit	1.09	0.38	0.28	1.51	1.85	1.55	3.12	2.52	0.73	0.68
OPM %	5.01	2.14	1.56	7.26	4.81	6.65	12.23	10.75	4.41	3.36
Other Income	-4.30	-9.26	-2.13	-4.72	-5.17	-2.18	7.15	6.13	5.33	1.35
Interest	0.21	0.27	0.16	0.32	0.45	0.26	0.30	0.28	0.16	0.09
Depreciation	0.43	0.46	0.40	0.43	0.78	0.39	0.39	0.39	0.39	0.41
Profit Before Tax	-3.85	-9.61	-2.41	-3.96	-4.55	-1.28	9.58	7.98	5.50	1.52
Tax %	-0.78	0.00	0.00	0.00	-0.66	-14.06	0.00	0.00	0.00	0.00
Net Profit	-3.88	-9.61	-2.41	-3.96	-4.57	-1.46	9.58	7.98	5.50	1.52
EPS in Rs	-1.35	-3.36	-0.84	-1.35	-1.56	-0.54	3.25	2.71	1.87	0.52

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	77	91	63	79	83	108
Expenses	77	105	90	76	78	100
Operating Profit	0.52	-14	-26	3.22	4.94	8.03
OPM %	0.67	-15.63	-41.80	4.05	5.98	7.43
Other Income	0.73	0.80	-2.74	-20	-12	-4.92
Interest	3.10	3.10	2.18	0.84	1.03	1.33
Depreciation	7.14	7.35	7.03	1.77	1.60	1.99
Profit Before Tax	-8.99	-24	-38	-20	-9.79	-0.21
Tax %	-115.44	19.19	19.09	-0.13	-1.79	-95.24
Net Profit	-19	-19	-31	-20	-9.97	-0.41
EPS in Rs	—	-5.92	-9.03	-6.76	-4.28	8.35
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	25	25	25	26	29
Reserves	54	63	49	39	69
Borrowings	31	25	6.51	5.64	7.58
Other Liabilities	52	83	29	19	18
Total Liabilities	162	196	110	90	124
Fixed Assets	108	110	15	14	14
CWIP	0.83	15	0.00	0.00	0.00
Investments	0.02	0.06	64	43	74
Other Assets	54	71	31	34	36
Total Assets	162	196	110	90	124

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	4.46	-37	-14	-9.68	2.63
Cash from Investing Activity	-5.13	-25	0.49	0.18	-45
Cash from Financing Activity	1.16	64	11	9.60	42
Net Cash Flow	0.49	1.72	-2.58	0.10	-0.08

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jan 2025	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	63.59%	63.59%	63.59%	63.59%	63.59%	59.06%	52.62%	52.62%	52.62%	52.62%	52.62%	52.62%
FIIs	0.00%	0.00%	0.00%	0.00%	0.02%	0.01%	0.00%	0.05%	0.00%	0.01%	0.09%	0.17%
DIIs	2.46%	3.86%	3.86%	3.86%	3.86%	3.86%	9.90%	10.38%	10.38%	10.38%	10.38%	10.38%
Public	33.94%	32.55%	32.55%	32.55%	32.53%	37.08%	37.48%	36.95%	37.00%	37.00%	36.91%	36.84%
Total Shareholders	10,686	10,028	11,432	11,543	11,282	10,521	10,375	10,537	10,317	10,078	10,532	10,741

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.